Shots:

• Elevian generated a seed funding of $5.5M from investors including WTI- Stanford StartX- Longevity Fund- Kizoo Ventures- Thynk Capital among others
• Its founders focus on regenerative effects of young blood and identified a specific circulating factor GDF11- by experimenting circulatory systems of young and old mice and observed regeneration of many tissues and organs in the old mice after 30 days
• GDF11 (a growth differentiation factor 11) reduces age-related cardiac hypertrophy- accelerates skeletal muscle repair- improves exercise capacity and brain function. Elevian will focus on is CAD- Alzheimer disease- T2D and sarcopenia- an age-related muscle dysfunction disorder

Ref: Elevian | Image: Elevian